AGILUS 120 mg, powder for solution for injection 6 bottles
Active ingredients: DANTROLÈNE SODIQUE HÉMIHEPTAHYDRATÉ
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for solution for injection6 bottlesintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AGILUS 120 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 6 flacons en verre
- Marketing authorisation holder
- NORGINE (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Apr 2025
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62862068CIP75510164CIP133400955101642Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DANTROLÈNE SODIQUE HÉMIHEPTAHYDRATÉpoudre | 120 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.